Tranquil Healthcare Fund I, LLC
Tranquil Healthcare Fund I, LLC ("Tranquil" or the "Company") is a private company formed to finance the buildout and expansion of Transcranial Magnetic Stimulation (“TMS”) clinics nationwide. Rather than operating the clinics directly, Tranquil's model is to provide commercial loans and advisory support to experienced third-party operators in exchange for interest income, consulting fees, and sale proceeds of the clinics it finances.
Tranquil's experienced leadership team combines healthcare, capital markets, business development, and direct-to-consumer (DTC) marketing expertise with a track record of execution, positioning Tranquil to participate in the growing demand for mental health treatment infrastructure across the United States.
TMS is a non-invasive neuromodulation therapy used primarily to treat mental health disorders, particularly in patients who have not responded adequately to conventional pharmacologic treatments. The therapy uses magnetic pulses to stimulate targeted regions of the brain associated with mood regulation. Since receiving FDA regulatory clearance in the United States in 2008 for adults with major depressive disorder ("MDD") who have not improved on a prior antidepressant treatment, TMS has become an increasingly accepted clinical intervention, with additional indications cleared in subsequent years.